Dr. Yusuf Qamruzzaman, MD

  • Royal Oak, MI
  • Hematologist and oncologist
NPI1174738231PAC ID1658519590
Medicare services, 2024
49,044
Medicare patients, 2024
622
Part D claims, 2024
1,080
Publications
3
Hospital affiliations
5
Practice address
3601 W Thirteen Mile Rd, Royal Oak, MI 48073
Practice phone
Call (248) 898-5400
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Qamruzzaman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Yusuf Qamruzzaman is a hematologist and oncologist in Royal Oak, Michigan

Dr. Qamruzzaman practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Qamruzzaman's NPI, 1174738231, was assigned on May 11, 2007. Dr. Qamruzzaman graduated from Wayne State University School of Medicine in 2007. Dr. Qamruzzaman holds Michigan license 4301104226.

NPI and contact details
Medicare PAC ID
1658519590
NPI enumeration date
May 11, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(248) 898-5400
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
45
Medical school graduation
2007

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Yusuf Qamruzzaman practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan

Dr. Qamruzzaman's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Source: Dmand AI Affiliation Data

Dr. Yusuf Qamruzzaman is affiliated with 8 sites of care and 3 medical groups

Dr. Qamruzzaman's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Qamruzzaman is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Qamruzzaman to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

See all 11 affiliations for Dr. Qamruzzaman

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Yusuf Qamruzzaman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Qamruzzaman practices, 8 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Corewell Health William Beaumont University HospitalAvailable with a free account
+7 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Qamruzzaman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Corewell Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Yusuf Qamruzzaman is one of 298 hematologists and oncologists in Michigan

Hematology and oncology is Dr. Qamruzzaman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Qamruzzaman is board certified in hematology by the American Board of Internal Medicine. Dr. Qamruzzaman is licensed in Michigan.

Specialties and state licenses

  • Hematology and oncology, MichiganPrimaryLicense 4301104226 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Qamruzzaman

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Yusuf Qamruzzaman billed Medicare for 49,044 services in 2024

CMS data shows 49,044 Medicare services from Dr. Qamruzzaman across 51 procedure codes in 2024, for 622 Medicare patients. Medicare paid $639,548 for them.

Medicare services, 202449,044
Medicare patients622
Paid by Medicare$639,548
Procedure codes51

Dr. Qamruzzaman's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 20,5652024: 32,23657%
Other services
2023: 30,6302024: 9,79368%
Lab and pathology
2023: 2,6022024: 2,99315%
Office and hospital visits
2023: 1,4442024: 1,4063%
Tests and treatments
2023: 1,5642024: 1,39911%
Surgery
2023: 1,2192024: 1,217No change

Where Dr. Qamruzzaman's Medicare services took place, 2024

  • In an office48,69199%
  • In a facility3531%

Dr. Qamruzzaman compared with the Michigan median for hematologists and oncologists, 2024

  • Dr. Qamruzzaman
  • Michigan median
Medicare services
49,044vs 61979.2 times
Medicare patients
622vs 2282.7 times
Part D claims
793vs 3782.1 times

Medians across 291 hematologists and oncologists in Michigan with Dmand AI profiles that report each measure.

Dr. Qamruzzaman's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Qamruzzaman

Need commercial claims for Dr. Qamruzzaman?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Qamruzzaman and other hematologists and oncologists in Michigan.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Yusuf Qamruzzaman treated 622 Medicare patients in 2024, average age 75

CMS counts 622 Medicare patients who saw Dr. Qamruzzaman in 2024. The largest group is 65 to 74, with 247 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Qamruzzaman's median patient age at 70, with 59% women.

Medicare patients, 2024622
Average age75
Average risk score2.26
Also on Medicaid11%

Dr. Qamruzzaman's Medicare patients by age, 2024

Dr. Qamruzzaman's Medicare patients by sex, 2024

  • Women34255%
  • Men28045%

Chronic conditions among Dr. Qamruzzaman's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis50%
  4. Cancer48%
  5. Ischemic heart disease43%
  6. Chronic kidney disease42%
  7. Diabetes33%
  8. Mood disorders32%

Share of Medicare patients with each condition. A patient can have several.

Dr. Qamruzzaman's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women59%
  • Men40%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Yusuf Qamruzzaman wrote 1,080 Medicare Part D claims in 2024

In 2024, Dr. Qamruzzaman wrote 1,080 Medicare Part D claims for 212 patients. 74% of them were for generic drugs. CMS names the drug for 793 of them, across 26 drugs with 11 or more claims each, at $2,195,973 in total drug cost. In 2023, CMS named 932 claims across 34 drugs.

Part D claims, 20241,080
Drugs named by CMS26
Total drug cost$2.2M
Part D patients212

Dr. Qamruzzaman's Part D claims by kind of drug, 2024

  • Generic798 claims74%
  • Brand-name282 claims26%

Dr. Qamruzzaman's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Qamruzzaman's Part D claims, 2024

  • Opioids3%34 of 1,080 claims
  • Antibiotics3%33 of 1,080 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 9322024: 79315%

Drugs named by CMS: 26 in 2024, 34 in 2023.

See all prescribing by Dr. Qamruzzaman

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Yusuf Qamruzzaman offers telehealth to Medicare patients

Dr. Qamruzzaman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Qamruzzaman as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Qamruzzaman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Yusuf Qamruzzaman has 3 publications on record

Dmand AI links 3 papers to Dr. Qamruzzaman, published from 2010 to 2021. Dr. Qamruzzaman's most frequent co-authors are Ervin A. Hire, MD, Yves A. Lussier, MD and Karina Adriana Serban, MD.

Papers3
Years published2010 to 2021

Dr. Qamruzzaman's papers by year, 2010 to 2021

Dr. Qamruzzaman's most frequent co-authors

Recent publications by Dr. Qamruzzaman

See all 3 publications and co-authors

See who Dr. Qamruzzaman researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Qamruzzaman works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Yusuf Qamruzzaman received $5,569 in industry payments from 2016 to 2025

CMS Open Payments shows 288 general payments to Dr. Qamruzzaman from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $578.

General payments to Dr. Qamruzzaman by program year, 2016 to 2025

General payments to Dr. Qamruzzaman by kind, 2016 to 2025

$5.6Kin total
  • Food and beverage$5,52099%
  • Education$491%

Companies that paid Dr. Qamruzzaman the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Qamruzzaman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Yusuf Qamruzzaman graduated from Wayne State University School of Medicine

Dr. Qamruzzaman graduated from Wayne State University School of Medicine in 2007.

  1. Medical schoolWayne State University School of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Yusuf Qamruzzaman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Yusuf Qamruzzaman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Yusuf Qamruzzaman's NPI number?

Dr. Yusuf Qamruzzaman's NPI number is 1174738231. It was assigned on May 11, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Yusuf Qamruzzaman?

Dr. Yusuf Qamruzzaman is a hematologist and oncologist in Royal Oak, Michigan. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Yusuf Qamruzzaman practice?

Dr. Qamruzzaman practices at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073. Dr. Qamruzzaman's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dmand AI also links Dr. Qamruzzaman to 3 hospitals, 3 group practices and clinics and 2 medical groups.

What is Dr. Yusuf Qamruzzaman's office phone number?

The practice phone on file for Dr. Qamruzzaman is (248) 898-5400.

What is Dr. Yusuf Qamruzzaman's medical license number?

Dr. Qamruzzaman holds Michigan license 4301104226.

Which hospitals is Dr. Yusuf Qamruzzaman affiliated with?

Dr. Qamruzzaman practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan. Dr. Qamruzzaman is also affiliated with Corewell Health Beaumont Troy Hospital. Dmand AI links Dr. Qamruzzaman to 3 more hospitals.

What medical group is Dr. Yusuf Qamruzzaman part of?

Dr. Qamruzzaman is linked to Beaumont Medical Group - Specialty Services. Dmand AI links Dr. Qamruzzaman to 2 more medical groups.

Does Dr. Yusuf Qamruzzaman accept Medicare?

Yes. CMS data shows Dr. Qamruzzaman billed Medicare for 49,044 services in 2024, and Dr. Qamruzzaman accepts Medicare assignment.

Does Dr. Yusuf Qamruzzaman offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Qamruzzaman as offering telehealth services.

How many Medicare patients does Dr. Yusuf Qamruzzaman see?

CMS counts 622 Medicare patients who saw Dr. Qamruzzaman in 2024, with an average age of 75.

Show 8 more questionsShow fewer questions

Is Dr. Yusuf Qamruzzaman board certified?

Yes. Dr. Qamruzzaman is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Yusuf Qamruzzaman bill to Medicare?

In 2024, Dr. Qamruzzaman's most billed Medicare services were injected or infused drug (J1439), medicare temporary code (Q0138) and injected or infused drug (J9271).

Where did Dr. Yusuf Qamruzzaman go to medical school?

Dr. Qamruzzaman graduated from Wayne State University School of Medicine in 2007.

What drugs does Dr. Yusuf Qamruzzaman prescribe most?

In 2024 Medicare Part D data, Dr. Qamruzzaman's most prescribed drugs by claims were Letrozole, Eliquis and Prochlorperazine Maleate.

Has Dr. Yusuf Qamruzzaman received payments from drug or device companies?

CMS Open Payments shows $5,569 in general payments to Dr. Qamruzzaman from 51 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Yusuf Qamruzzaman been practicing?

Dr. Qamruzzaman graduated from medical school in 2007, 19 years ago.

Does Dr. Yusuf Qamruzzaman do research?

Dmand AI links 3 publications to Dr. Qamruzzaman, published from 2010 to 2021.

Who does Dr. Yusuf Qamruzzaman publish with?

Dr. Qamruzzaman's most frequent co-authors are Ervin A. Hire, MD (1 shared paper), Yves A. Lussier, MD (1 shared paper) and Karina Adriana Serban, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Michigan by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)